Promescent Lidocaine Spray — Competitive Intelligence Brief

Promescent Lidocaine Spray (Promescent Lidocaine Spray) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Topical local anesthetic. Area: Urology / Sexual Health.

phase 3 Topical local anesthetic Voltage-gated sodium channels Urology / Sexual Health Small molecule

Target snapshot

Promescent Lidocaine Spray (Promescent Lidocaine Spray) — Eugene Y Rhee, MD. Lidocaine spray topically anesthetizes nerve endings in penile tissue to reduce sensory stimulation and delay ejaculation.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Promescent Lidocaine Spray TARGET	Promescent Lidocaine Spray	Eugene Y Rhee, MD	phase 3	Topical local anesthetic	Voltage-gated sodium channels
Perineural Dexamethasone and bupivacaine	Perineural Dexamethasone and bupivacaine	Sherif Mohamed Abd el moneim Soaida, MD	marketed	Local anesthetic with adjuvant corticosteroid	Voltage-gated sodium channels (bupivacaine); glucocorticoid receptor (dexamethasone)
Levobupivacaine wound infiltration	Levobupivacaine wound infiltration	University of Genova	marketed	Local anesthetic (amide)	Voltage-gated sodium channels
Dexamethasone+ Bupivacaine	Dexamethasone+ Bupivacaine	Ain Shams University	marketed	Corticosteroid + Local anesthetic combination	Glucocorticoid receptor (dexamethasone); Voltage-gated sodium channels (bupivacaine)
Hyperbaric bupivacaine+Morphine	Hyperbaric bupivacaine+Morphine	Fundación Pública Andaluza Progreso y Salud	marketed	Local anesthetic + opioid combination	Voltage-gated sodium channels (bupivacaine); mu opioid receptors (morphine)
Ropivacaine/Fentanyl	Ropivacaine/Fentanyl	National Institute for Tuberculosis and Lung Diseases, Poland	marketed	Local anesthetic with opioid analgesic combination	Voltage-gated sodium channels (ropivacaine); mu opioid receptor (fentanyl)
Lidocaine-chlorprocaine combination	Lidocaine-chlorprocaine combination	Hadassah Medical Organization	marketed	Local anesthetic combination	Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Topical local anesthetic class)

1. American University of Beirut Medical Center · 1 drug in this class
2. Brown, Theodore R., M.D., MPH · 1 drug in this class
3. Eugene Y Rhee, MD · 1 drug in this class
4. IWK Health Centre · 1 drug in this class
5. The University of Texas Health Science Center, Houston · 1 drug in this class